Nevertheless, decreasing acyl ghrelin concentration peripherally with CF801 or with other bona fide GOAT inhibitors, may prove to be a desirable option for the treatment of obesity without affecting the functionality of the ghrelin receptor in the CNS. The gene discussed is MBOAT4; the disease is obesity due to melanocortin 4 receptor deficiency.